Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap. The company was founded in 1995 and their first product Diabact UBT, a breath test for diagnosing the causative agent of stomach ulcers (Helicobacter pylori), was introduced in 2000. In 2003, the company adopted the name Orexo and in 2005 the company was listed on the Stockholm Stock Exchange. On March 29, 2019 a U.S. jury rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd. infringed a patent for Orexo’s biggest drug, Zubsolv. More information...
According to PR-model, orexo.com is ranked 1,756,639th in multilingual Wikipedia, in particular this website is ranked 1,038,039th in English Wikipedia.
The website is placed before journalistefreelance.be and after ourtimes.wordpress.com in the BestRef global ranking of the most important sources of Wikipedia.
